Pharmaceuticals & Drugs
AUROPHARMA
Aurobindo Pharma Ltd.
Strong momentum structure
Setup readiness
Early Trend
- Entry Zone
- ₹1518.6-1557.8
- Support Level
- ₹1482.5
- Resistance
- ₹1860.0
- Risk / Reward
- 4.0 : 1
- Risk Distance
- 4.8% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Constructive setup
Structure shows workable momentum characteristics with selective risks to monitor.
Bullish factors
- Price is approaching the pivot zone.
- 1 prior pivot rejection in last 60d (-8 pts).
- ATR shrinking 3 consecutive weeks — coil forming.
- BB squeeze — energy building.
- MACD positive and rising — confirmation only (no bonus).
- RSI 59 — ideal setup zone.
Risk factors
- 5 distribution days recently — institutional selling
Why not 100?
- RS rank is below elite leadership band (<90)
- Volume quality is not in top confirmation range yet
Overall view
Constructive setup — key momentum and institutional cues are broadly aligned for continued research.
Trade management framework
Research framework only. Use your own risk controls.
- If price moves +1R, consider reducing downside by moving stop closer to entry.
- If price reaches around +1.5R to +2R, consider partial profit booking (for example 20-30%).
- If trend extends beyond +2R, consider trailing below a fast trend reference (for example 21 EMA).
Setup research
AUROPHARMA — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Why now
Coiled at the pivot — breakout trigger is imminent
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#26/42)
- Relative strength Building (RS 72)
- Trend strength Weak (ADX 16)
What invalidates it
This idea is wrong below ₹1482.5 (0.6% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹1482.5
- Pivot — failure re-entry below₹1550.0
Risk distance
Risk ≈ ₹75.23/share from entry ₹1557.8.
Reasons to skip 1
Disqualifiers that apply even if the score looks good.
- 5 distribution days recently — institutional selling
AUROPHARMA Support & Resistance Levels
Research chart
Daily price action with entry, stop, and target levels from our latest scan, plus relative strength vs Nifty.
Entry zone, stop and targets are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Trader brief
What to understand
AUROPHARMA Entry, Stop-Loss & Targets
Research heuristic · not a buy/sell call
Solid scanner setup worth tracking. The main question is timing: confirm the base is still tightening and relative strength is not rolling over before sizing risk.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Setup highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Setup metrics Very Strong
AUROPHARMA Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Structure
Momentum
Risk
More scanner fields
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
AUROPHARMA FAQ Common swing-trading questions
Frequently asked questions about AUROPHARMA
Is AUROPHARMA a good swing trade right now?
On Swing Edge's swing-setup framework, Aurobindo Pharma Ltd. (AUROPHARMA) currently grades B — workable setup. Coiled at the pivot — breakout trigger is imminent. Flagged today. This is educational research, not investment advice.
What are AUROPHARMA's support and resistance levels?
For AUROPHARMA, near-term support sits around ₹1,482.5 (the base/stop zone); overhead resistance is around ₹1,550.0 (the breakout pivot); the next resistance above is ₹1,860.0. This is educational research, not investment advice.
What is the breakout / pivot level for AUROPHARMA?
The breakout pivot for AUROPHARMA is around ₹1,550.0. Price is about 3.8% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is AUROPHARMA above its 50-day and 200-day moving averages?
Yes — AUROPHARMA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is AUROPHARMA versus the market (RS rank)?
AUROPHARMA has a relative strength (RS) rank of 72 out of 100 versus the NSE universe, making it building relative strength and outperforming the broader market. Trend strength (ADX) reads 16, indicating a weak/choppy trend. This is educational research, not investment advice.
What are the entry, stop-loss and target levels for AUROPHARMA?
Reference swing levels for AUROPHARMA: entry around ₹1,557.8, stop-loss around ₹1,482.5, targets at ₹1,860.0 and ₹1,999.6. That works out to roughly a 4.0:1 reward-to-risk on the first target. These are reference levels for study only — this is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-22 — not live intraday NSE quotes.